Stay updated on Anti-CD38 Antibody Trial in CD38+ Malignancies
Sign up to get notified when there's something new on the Anti-CD38 Antibody Trial in CD38+ Malignancies page.

Latest updates to the Anti-CD38 Antibody Trial in CD38+ Malignancies page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe Locations section was updated with new trial sites across the United States and internationally, and several existing locations were removed.SummaryDifference2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedPubMed publications note reworded to indicate automatic filling from PubMed, and the page revision updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check49 days agoChange DetectedRemoved the government funding lapse banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check63 days agoChange DetectedThe new screenshot shows the same study detail page with only minor formatting/layout adjustments and no changes to core content such as study arms, eligibility criteria, outcomes, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check92 days agoChange DetectedMajor update: version bumped to v3.2.0 with a critical operating-status notice; previous version tag v3.1.0 removed.SummaryDifference1.0%

- Check99 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or update a Ubuntu-style versioning tag.SummaryDifference0.0%

Stay in the know with updates to Anti-CD38 Antibody Trial in CD38+ Malignancies
Enter your email address, and we'll notify you when there's something new on the Anti-CD38 Antibody Trial in CD38+ Malignancies page.